Cargando…

Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial

Acute myeloid leukemia (AML) can affect individuals of all ages, but is more common in older adults. It has been estimated that AML accounted for 1% of all newly diagnosed cancers in the USA in 2022. The diagnostic process varies depending on the presenting symptoms and the healthcare facility that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genç, Emine Eylem, Saraç, İrem Sena, Arslan, Hayrunnisa, Eşkazan, Ahmet Emre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182356/ https://www.ncbi.nlm.nih.gov/pubmed/37178373 http://dx.doi.org/10.1007/s40487-023-00229-4

Ejemplares similares

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
por: Tiribelli, Mario, et al.
Publicado: (2019)

New kid on the block: C-reactive protein-to-albumin ratio as a new prognostic marker for chronic lymphocytic leukemia: Comment on “C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases”
por: Küçükyurt, Selin, et al.
Publicado: (2021)

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
por: Keskin, Dilek, et al.
Publicado: (2016)

Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2013)

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2013)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Tackling TKI resistance in AML: A commentary on “Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.” by Yamatani et al.
por: Hatırnaz Ng, Özden, et al.
Publicado: (2022)

COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey
por: Yılmaz, Umut, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the regular follow-up and outcomes of patients with chronic myeloid leukemia in chronic-phase
por: Yılmaz, Umut, et al.
Publicado: (2022)

Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.
por: Tanrıkulu Şimşek, Eda, et al.
Publicado: (2022)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
por: Ortaboz, Damla, et al.
Publicado: (2023)

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
por: Küçükyurt, Selin, et al.
Publicado: (2023)

Therapy‐related chronic myeloid leukemia in a patient receiving peptide receptor radionuclide therapy for pancreatic neuroendocrine tumor
por: Kucukyurt, Selin, et al.
Publicado: (2020)

Upregulation of SPINK2 in acute myeloid leukemia
por: Gezer, Sümbül, et al.
Publicado: (2023)

Synchronous Detection of Hairy Cell Leukemia and HIV-Negative Kaposi's Sarcoma of the Lymph Node: A Diagnostic Challenge and a Rare Coincidence
por: Aydin, Seniz Ongoren, et al.
Publicado: (2011)

Lost in Translation: Obstacles to Translational Medicine
por: Mankoff, Stacey P, et al.
Publicado: (2004)

The Specific Carbohydrate Diet: Obstacle and Opportunities
por: Rufo, Paul A.
Publicado: (2022)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Chronic myeloid leukemia data from India
por: Bansal, Shweta, et al.
Publicado: (2013)

Acute myeloid leukemia: leukemia stem cells write a prognostic signature
por: Gudgin, Emma J, et al.
Publicado: (2011)

The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
por: Saydam, Guray, et al.
Publicado: (2022)

Rewiring of the Transcription Factor Network in Acute Myeloid Leukemia
por: Assi, Salam A, et al.
Publicado: (2019)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities
por: Chen, Yong-Feng, et al.
Publicado: (2023)

Drivers of and Obstacles to the Adoption of Toxicogenomics for Chemical Risk Assessment: Insights from Social Science Perspectives
por: Pain, Guillaume, et al.
Publicado: (2020)

Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C.
Publicado: (2013)

Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
por: Azenkot, Tali, et al.
Publicado: (2022)

Human biomonitoring data interpretation and ethics; obstacles or surmountable challenges?
por: Sepai, Ovnair, et al.
Publicado: (2008)

Overcoming obstacles to implementing a primary care research framework
por: Cardarelli, Roberto, et al.
Publicado: (2007)

Chronic myeloid leukemia: An Indian scenario
por: Digumarti, Raghunadharao
Publicado: (2016)

Obstacles and opportunities for the future of genomic medicine
por: Solomon, Benjamin D
Publicado: (2014)

Chronic Myeloid Leukemia: Atypical Presentation and Diagnostic Pitfall in the Workup of Isolated Thrombocytosis
por: Findakly, Dawood, et al.
Publicado: (2020)

Oncogenic signaling: new insights and controversies from chronic myeloid leukemia
por: Van Etten, Richard A.
Publicado: (2007)

Introducing oral tobacco for tobacco harm reduction: what are the main obstacles?
por: Martinet, Yves, et al.
Publicado: (2007)

Overcoming obstacles along the pathway to integration for Syrian healthcare professionals in Germany
por: Abbara, Aula, et al.
Publicado: (2019)

Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia
por: Öztaş, Mert, et al.
Publicado: (2021)

Simultaneous Detection of B-Cell Chronic Lymphocytic Leukemia and Colon Adenocarcinoma in the Same Mesenteric Lymph Node
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2013)

PB2191: A RETROSPECTIVE MULTI-CENTER STUDY ON DIRECT ORAL ANTICOAGULANT USE IN BCR::ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
por: Baysal, Mehmet, et al.
Publicado: (2023)

Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis
por: Dalton, William Brian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0pmp6dkvul2i23cfageob3a26b